Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancer
Zohreh Najminejad, Fatemeh Dehghani, Yousef Mirzaei, Ali Hussein Mer, Seyyed Amirreza Saghi, Mohadeseh Haji Abdolvahab, Nader Bagheri, Anna Meyfour, Ameneh Jafari, Saeed Jahandideh, Tohid Gharibi, Zahra Amirkhani, Hamed Delam, Noushin Mashatan, Hosein Shahsavarani, Meghdad Abdollahpour‐Alitappeh
Topics & Concepts
Breast cancerAntibody-drug conjugateDrugAntibodyTrastuzumabConjugateMedicineCancerTrastuzumab emtansineImmunologyOncologyCancer researchPharmacologyInternal medicineMonoclonal antibodyMathematicsMathematical analysisHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyAdvanced Breast Cancer Therapies